SCHEMBL28026697

SCHEMBL28026697

CCN1C(=O)C(=O)c2ccc(Br)cc21

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARK7 Q99497 1/20 0.53
CUL4A Q13619 1/20 0.51
CES1 P23141 5/20 0.50
ACHE P22303 3/20 0.50
ALDH1A1 P00352 5/20 0.48
ALDH2 P05091 3/20 0.48
ALDH3A1 P30838 3/20 0.48
CHRM5 P08912 1/20 0.46
CHRM1 P11229 1/20 0.46
CHRM3 P20309 1/20 0.46
CYP1B1 Q16678 2/20 0.43
TSHR P16473 1/20 0.43
S100A4 P26447 1/20 0.42
HSP90AA1 P07900 1/20 0.41
MAPT P10636 1/20 0.41
PKM P14618 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
BCHE P06276 2/20 0.41
TGM2 P21980 1/20 0.41
CDC25A P30304 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22667286 0.86 CUL4A (0.68) PARK7CUL4ACES1ACHEALDH1A1
SCHEMBL30403461 0.86 CUL4A (0.68) PARK7CUL4ACES1ACHEALDH1A1
SCHEMBL28417115 0.84 ALDH1A1 (0.57) CUL4ACES1ACHEALDH1A1ALDH2
SCHEMBL28417285 0.82 CES1 (0.65) CUL4ACES1ACHEALDH1A1ALDH2
SCHEMBL6176718 0.81 ALDH1A1 (0.45) CUL4ACES1ACHEALDH1A1ALDH2
SCHEMBL16075218 0.80 ALDH1A1 (0.47) CUL4ACES1ACHEALDH1A1ALDH2
SCHEMBL16064931 0.80 ALDH1A1 (0.47) CUL4ACES1ACHEALDH1A1ALDH2
SCHEMBL16064397 0.80 ALDH1A1 (0.47) PARK7CUL4ACES1ACHEALDH1A1
SCHEMBL29411355 0.79 APAF1 (0.60) PARK7CES1ALDH1A1ALDH2ALDH3A1
SCHEMBL25865292 0.79 ACHE (0.47) PARK7CUL4ACES1ACHEALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119798230-A Indolone compounds and application thereof in treating acute and chronic liver diseases and promoting tissue repair 中国药科大学 2025-04-11 CN claimed
US-20260008760-A1 DIPEPTIDYL PEPTIDASE 1 INHIBITORS AND USES THEREOF INSMED INCORPORATED 2026-01-08 US disclosed
CN-119798230-A Indolone compounds and application thereof in treating acute and chronic liver diseases and promoting tissue repair 中国药科大学 2025-04-11 CN disclosed
CN-104829608-A Coumarin-thiazole-indolone compounds, and preparation method and application thereof UNIV JISHOU 2015-08-12 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260008760-A1 DIPEPTIDYL PEPTIDASE 1 INHIBITORS AND USES THEREOF DPP9, DPP7, DPP4 PARK7 1549/4885CUL4A 2346/4885CES1 10/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.